Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by skier59on Dec 30, 2020 6:20pm
93 Views
Post# 32200210

RE:RE:RE:Patience with this one

RE:RE:RE:Patience with this oneSorry you're wrong dude. takes 8 warrants to get 1 common share. So if the SP is $6.10 the warrants should be $6.10 - .72 = $5.38 / 8 = 67 cents = 10 bagger like the common.

However, I'm invested in both the common and the warrant. Reason being, is that let's say you sell 10,000 shares at 72. $7200/.06 = 120,000 warrants

If and when the SP gets to $10.....and I want to cash out. 120,000/8=15,000 shares
15,000 x .72 = $10,800 conversion cost + initial cost $7,200 = $18,000 total investment
$150,000 - $18,000 = $132,000 profit

10,000 shares @ .72 = $7200 cause I only have $7200 so do I buy shares or warrants?

$10 SP x 10,000 shares = $100,000 - initial investment $7200 = $92,800 profit


BoredAccountGuy wrote:
wrong. There's SZLS.wt The exercise price is $1.10 per share. SZLS.wt is currently trading for 5.5 cents. If the stock goes to $6.10 the warrants should be at least $5.50 which would make it a 100 bagger


<< Previous
Bullboard Posts
Next >>